Transcriptional activation of c-fos protooncogene by 17β-Estradiol: Mechanism of aryl hydrocarbon receptor-mediated inhibition

Molecular Endocrinology

Volumn 13, Issue 9, 1999, Pages 1511-1521

  Duan, Renqin ^a   Porter, Weston ^a   Samudio, Ismael ^a   Vyhlidal, Carrie ^b   Kladde, Michael ^b   Safe, Stephen ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ALPHA NAPHTHOFLAVONE; AROMATIC HYDROCARBON RECEPTOR; CHLORAMPHENICOL ACETYLTRANSFERASE; DIOXIN; DNA; ESTRADIOL; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ONCOGENE C FOS; PRIORITY JOURNAL;

BACTERIA (MICROORGANISMS); EUKARYOTA; FELIS CATUS; MINK CELL FOCUS-FORMING VIRUS;

EID: 0033305212     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.9.0338     Document Type: Article

References (60)

1. The structure and function of the fos proto-oncogene
2. Fos and jun: The AP-1 connection
3. The fos oncogene
4. Cellular and viral fos genes: Structure, regulation of expression and biological properties of their encoded products
5. The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes
6. Common DNA binding site for Fos protein complexes and transcription factor AP-1
7. Effects of steroid hormones and peptide growth factors on protooncogene c-fos expression in human breast cancer cells
8. Estrogen regulation of protooncogenes coding for nuclear proteins
9. Stimulation of TPA-responsive element activity by a cooperative action of insulin and estrogen in human breast cancer cells
10. Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells
11. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: Role of estrogen receptor Sp1 complex formation
12. 17 β-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation
13. Oestrogen directly stimulates growth factor signal transduction pathways in human breast cancer cells
14. A composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter
15. Differential stimulation of Fos and Jun family members by calcitriol in osteoblastic cells
16. Parathyroid hormone induces sequential c-fos expression in bone cells in vivo: In situ localization of its receptor and c-fos messenger ribonucleic acids
17. The ability of a ternary complex to form over the serum response element correlates with serum inducibility of the human c-fos promoter
18. Growth hormone regulates ternary complex factors and serum response factor associated with the c-fos serum response element
19. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C
20. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors
21. Nerve growth factor activates a ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB
22. Growth factor-induced gene expression: The ups and downs of c-fos regulation
23. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation
24. c-fos Sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore
25. Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sites
26. TFII-I Enhances activation of the c-fos promoter through interactions with upstream elements
27. Activation of c-fos gene expression by a kinase-deficient epidermal growth factor receptor
28. The serum response element can mediate induction of c-fos by growth hormone
29. Functional synergy between the transcription factor Sp1 and the estrogen receptor
30. Estrogen-induced retinoic acid receptor α1 gene expression: Role of estrogen receptor-Sp1 complex
31. Identification of a functional imperfect estrogen responsive element in the 5'-promoter region of the human cathepsin D gene
32. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions
33. Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
34. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer
35. Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens
36. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
37. Antiestrogenic activity of TCDD and related compounds
38. Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetra-chlorodibenzo-p-dioxin (TCDD) in MCF-7 cells
39. Identification of a motif within the 5'-regulatory region on pS2 which is responsible for Ap1 binding and TCDD-mediated suppression
40. The Ah receptor signal transduction pathway
41. Mechanism of action of α-naphthoflavone as an Ah receptor antagonist in MCF-7 human breast cancer cells
42. Benzo[a]pyrene resistant (BaP(R)) human breast cancer cells: A unique aryl hydrocarbon (Ah)-nonresponsive clone
43. Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor
44. Functional and physical interactions between the estrogen receptor-Sp1 and the nuclear aryl hydrocarbon receptor complexes
45. Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex
46. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8- tetra-chlorodibenzo-p-dioxin (TCDD) in rats
47. Inhibition of 7,12-dimethyl-benzanthracene-induced rat mammary tumor growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin
48. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats
49. Correlation of in vitro and in vivo growth suppression of MCF-7 human breast cancer by 2,3,7,8-tetrachloro-dibenzo-p-dioxin
50. Inhibition of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor growth by aryl hydrocarbon receptor agonists
51. Aryl hydro-carbon receptor-mediated antiestrogenic and antitu-morigenic activity of diindolylmethane
52. HTLV-1 Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization
53. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene
54. CDK-Independent activation of estrogen receptor by cyclin D1
55. The price of repression
56. Characterization of the hormone responsive element involved in the regulation of the progesterone receptor gene
57. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription
58. Regulation of cathepsin D and pS2 gene expression by growth factors in MCF-7 human breast cancer cells
59. Antiestrogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17β-estradiol-induced pS2 expression
60. Direct study of DNA-protein interactions in repressed and active chromatin in living cells